INTRODUCTION
D-limonene 1-methyl-4-1-methylethenyl cyclohexene is one of the most common terpenes in nature, having a lemon-like sweet smell and being a major constituent in several citrus oils such as orange, lemon, mandarin, lime, and grapefruit. Owing to its pleasant citrus fragrance, D-limonene is widely used as a fl avour and fragrance additive in perfumes, soaps, foods, chewing gum, and beverages 1, 2 . D-limonene may also be used as an inert ingredient in pesticides and as a natural replacement for petroleumbased solvents in paints and cleaning products. It is considered to be an ingredient with relatively low toxicity. Upon oral administration, D-limonene is rapidly and almost completely absorbed from the gastrointestinal tract of both humans and animals 3, 4 . Other studies have shown that D-limonene does not pose a mutagenic, carcinogenic, or nephrotoxic risk to humans. At present, D-limonene is clini-cally used to dissolve cholesterol-containing gallstones and to relieve heartburn. It also has well-established chemopreventive activity against many types of cancers 1, 2, [5] [6] [7] . However, the anti-infl ammatory effects of D-limonene are as yet unknown. Therefore, we conducted a detailed study to investigate the anti-inflammatory effects of D-limonene in RAW 264.7 cells. Infl ammation is a complex process mediated by the activation of various immune cells. Macrophages play a central role in mediating many different immunopathological phenomena during infl ammation, including the overproduction of pro-infl ammatory cytokines and infl ammatory mediators, such as interleukin IL -1β, IL-6, tumour necrosis factor TNF -α, and nitric oxide NO synthesized by inducible NO synthase iNOS and prostaglandin PG E 2 synthesized by cyclooxygenase COX -2 [8] [9] [10] [11] . In murine macrophage RAW 264.7 cells, lipopolysaccharide LPS stimulation alone can induce the production of pro-infl ammatory cytokines and inflammatory mediators. Therefore, this cell system provides an excellent model for drug screening and evaluation of potential inhibitors of the infl ammatory response. In this study, we examine the effect of D-limonene on LPSstimulated production of pro-inflammatory cytokines and infl ammatory mediators by RAW 264.7 cells.
EXPERIMENTAL

Reagents
Foetal bovine serum FBS and Dulbecco s Modifi ed Eagle Medium DMEM were obtained from GIBCO Grand Island, NY . iNOS and COX-2 antibodies were purchased from Calbiochem San Diego, CA, USA and BD Biosciences San Diego, CA, USA . Recombinant mouse TNF-α, IL-1β, IL-6, and PGE 2 were purchased from R&D Systems Inc. St. Louis, MO . All other chemicals were from Sigma.
Cell culture
The murine macrophage cell line, RAW264.7, was purchased from ATCC Rockville, MD , maintained in DMEM supplemented with 100 U/mL of penicillin, 100 µg/mL of streptomycin, and 10 FBS. Cells were grown at 37 in humidified air containing 5 CO 2 and were sub-cultured every 3 days.
2.3 Measurement of nitrite NO 2 production using the Griess reaction RAW264.7 cells 1.5 10 5 cells/mL were pre-incubated for 18 h before treatment with LPS 1 μg/mL and various concentrations of D-limonene for a further 24 h. Nitrite in culture supernatants was measured by adding 100 μL of Griess reagent 1 sulfanilamide and 0.1 N- [1-naphthyl] ethylenediamine dihydrochloride in 5 phosphoric acid to 100 μL samples of medium. All measurements were performed in triplicate. The concentration of NO 2 was determined using a standard curve generated with NaNO 2 .
Western blot analysis
RAW 264.7 cells were pre-incubated for 18 h before cotreatment with LPS 1 μg/mL and test reagents for 24 h. After incubation, the cells were collected and washed twice with cold PBS. The cells were lysed in a lysis buffer [50 mM Tris-HCl pH 7.5 , 150 mM NaCl, 1 Nonidet P-40, 2 mM ethylenediamine tetraacetic acid EDTA , 1 mM ethylene glycol-bis β-amino-ethyl ether -N,N,N ,N -tetraacetic acid EGTA , 1 mM NaVO 3 , 10 mM NaF, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 25 μg/mL leupeptin] and kept on ice for 30 min. Cell lysates were centrifuged at 12,000 g at 4 for 15 min, and supernatants stored at 70 until required for analysis. Protein concentrations were measured using a protein assay kit Bio-Rad, HC, U. S.A. . Aliquots of the lysates 30 40 μg of protein were separated on a 8 12 sodium dodecyl sulphate SDS -polyacrylamide gel and transferred onto a polyvinylidene fluoride PVDF membrane Bio-Rad, HC, U.S.A. using a glycine transfer buffer [192 mM glycine, 25 mM Tris-HCl pH 8.8 , 20 MeOH v/v ]. After blocking nonspecific sites with 5 non-fat milk powder solution, membranes were incubated with a specific primary antibody mouse monoclonal anti-rabbit iNOS or anti-mouse COX-2 overnight at 4 . Membranes were further incubated for 1 h with a peroxidase-conjugated secondary antibody goat IgG, 1:5000; Santa Cruz, CA, U.S.A. . The immunoactive proteins were detected using an enhanced chemiluminescence ECL western blotting detection kit Amersham Pharmacia Biotech., NY, U.S.A. . 2 production by enzyme immunoassay RAW 264.7 cells 1. 5 10 6 cells/mL were pre-incubated for 18 h before co-treatment with LPS 1 μg/mL and D-limonene at various concentrations for 24 h. Culture medium was centrifuged at 12,000 rpm for 3 min at 4 to pellet cells. Culture supernatants were harvested for PGE 2 measurement using a mouse ELISA kit.
Measurement of PGE
Measurement of cell viability MTT assay
Cell viability was measured by conventional MTT assay. HaCaT cells 1.0 10 5 cells ⁄ mL were seeded on 96-well plates and cultured as described above for 18 h. At 4 h prior to culture termination, 10 µL of MTT solution 10 mg/mL in phosphate buffered-saline, pH 7.4 was added and the cells were continuously cultured until termination. The incubation was stopped by addition of 15 sodium dodecyl sulfate SDS into each well for solubilization of formazan and the optical density OD at 570 nm OD 570-630 was measured by a microplate reader.
Statistical analysis.
The Student s t-test was used to determine the statistical signifi cance of differences between values for a variety of experimental and control groups. Data are expressed as the mean standard error of the mean SEM of at least three independent experiments performed in triplicate. P values of 0.05 or less were considered statistically significant.
RESULTS
D-Limonene inhibits LPS-mediated production of ni-
trite In order to evaluate the capacity of D-limonene to inhibit iNOS, nitrite accumulation was examined in the culture medium of LPS-stimulated RAW 264.7 macrophages.
D-Limonene was added to the culture medium immediately prior to stimulation of RAW 264.7 macrophages with LPS, and the cells were incubated for 18 h. Thereafter, the nitrite in the culture medium was measured. As shown in Fig. 1A , D-limonene inhibited nitrite accumulation in a concentration-dependent manner. D-Limonene had no effect on cell viability at concentrations up to 0.04 , as assessed by the LDH method Fig. 1A . These results suggest that the inhibitory effects of D-limonene are not the result of cytotoxicity. As a positive control, we used 2-amino-4-methylpyridine, which inhibited NO production. Dexamethasone 20 μM did not affect NO production Fig. 1A . 3.2 D-Limonene decreases LPS-induced PGE 2 production in RAW 264.7 macrophages PGE 2 was measured in the supernatant of cultured RAW 264.7 macrophages stimulated with LPS 1 μg/mL for 18 h in the presence of D-limonene. While PGE 2 production by unstimulated cells was low data not shown , LPS stimulated an increase in PGE 2 production Fig. 1B . D-limonene and dexamethasone 20 μM both inhibited LPS-stimulated PGE 2 production in a concentration-dependent manner Fig. 1B .
D-Limonene inhibits LPS-stimulated iNOS protein expression
In order to elucidate the mechanism by which D-limonene inhibits LPS-stimulated nitrite production, we investigated its effect on iNOS protein expression. While barely detected in unstimulated RAW 264.7 macrophages by western blot analysis, robust expression of iNOS protein was observed after stimulation with LPS for 18 h Fig. 2 . The presence of D-limonene in LPS-stimulated cell cultures markedly inhibited the induction of iNOS expression in a concentration-dependent manner Fig. 2 . These data demonstrate that the inhibition of NO 2 production by D-limonene, observed in Fig. 1 , could have resulted from the inhibition of LPS-induced iNOS protein expression in RAW 264.7 macrophages.
D-Limonene inhibits COX-2 protein expression
To assess whether PGE 2 repression is a result of the inhibition of COX-2 by D-limonene, RAW 264.7 macrophages treated with D-limonene together with LPS for 18 h were subjected to western blot analysis. Figure 2 shows that D-limonene inhibits LPS-induced COX-2 protein expression in a concentration-dependent manner. This corroborates the above fi nding that D-limonene decreases LPS-stimulat-
Fig. 1 Inhibitory Effects of D-Limonene on A Nitric Oxide and (B PGE 2 Production and Cell Viability in RAW 264.7
Cells. The production of nitric oxide was assayed in the culture medium of cells stimulated with LPS (1 μg/mL for 24 h in the presence of D-limonene 0.01%, 0.02%, and 0.04% , 2-amino-4-methylpyridine 20 μM , and dexamethasone DEX; 20 μM . Cytotoxicity was determined using the LDH method. In the case of PGE 2 evaluation, supernatants were collected, and the PGE 2 concentration in the supernatants was determined by ELISA. Values are the mean ± SEM of triplicate experiments. *P < 0.05; **P < 0.01 ed PGE 2 production.
D-Limonene inhibits macrophage-cytokine production.
To assess the effects of D-limonene on TNF-α, IL-1β, and IL-6 production by activated macrophages, LPS-stimulated RAW 264.7 cells were incubated in the presence of increasing concentrations of D-limonene and cytokine concentrations in culture supernatants were measured by ELISA.
D-Limonene suppressed LPS-stimulated TNF-α, IL-1β, and IL-6 production in a dose-dependent manner Fig. 3 . A housekeeping protein, β-actin, was constitutively expressed and was unaffected by D-limonene treatment. Interestingly, of the two positive controls used, 2-amino-4-methyl pyridine did not affect production of the proinfl ammatory cytokines but dexamethasone 20 μM signifi cantly reduced them. Thus, D-limonene modulates the LPS-induced production of TNF-α, IL-lβ, and IL-6 in RAW 267.4 macrophages.
Cytotoxicity of D-limonene on human keratinocytes
HaCaT cells Finally, we examined the cytotoxic effects of D-limonene in HaCaT human keratinocyte cells to assess the suitability of this terpene for use as a therapeutic agent on the human skin. As shown in Fig. 4 , cell viability remained at almost 100 following treatment with D-limonene at concentrations up to the effective dose of 0.08 . These data suggest that D-limonene has low cytotoxicity against mammalian cell lines.
DISCUSSION
D-Limonene, a natural monoterpene occurring in citrus peels and other plants, is present in foods and in many essential oils. It is extensively used as a food additive to provide a citrus fl avour; as a fragrance in perfumes, air fresheners, and personal care products; and as a natural replacement for petroleum-based solvents in paints and cleaning products. D-limonene may also be used as an inert ingredient in pesticide formulations. Previously, we demonstrated that citrus essential oils, which contain D-limonene as a major component, are able to alleviate infl ammation 12, 13 . In order to validate the use of D-limonene as an anti-infl ammatory agent in the cosmetic industry, we have, in this study, investigated the effects of D-limonene on the production of pro-inflammatory cytokines and inflammatory mediators by LPS-activated RAW 264.7 macrophages. Macrophages play an important role in the initiation and amplifi cation of a variety of infl ammatory diseases. Therefore, the development of methods to reduce the number of activated macrophages, to inhibit the activation signals and/or their specifi c macrophage receptors, or to selectively counteract the macrophage products that act as disease amplifi ers has been suggested as a promising therapeutic approach against various infl ammatory diseases [14] [15] [16] .
Pro-infl ammatory cytokines and infl ammatory mediators such as COX-2, NO, IL-1β, IL-6, and TNF-α play important roles in the infl ammatory process. NO is derived from arginine after the activation of iNOS, and is an important effector molecule involved in immune regulation and defence. COX-2 catalyzes the production of prostaglandins, which represents an important step in the infl ammatory process. PGE 2 production in LPS-treated macrophages is primarily due to the transcriptional activation of the COX-2 gene. Thus, NO and COX-2 inhibitors are considered potential anti-infl ammatory agents [17] [18] [19] [20] . Therefore, in this study, we investigated the effects of D-limonene on the production of pro-inflammatory cytokines as well as NO and COX-2 in RAW 264.7 macrophages. After exposure to LPS, RAW 264.7 cells displayed elevated production of pro-infl ammatory cytokines and infl ammatory mediators. D-Limonene, at concentrations not producing evident cytotoxicity, dramatically prevented the production of NO, PGE 2 , IL-1β, IL-6, and TNF-α, as well as the expression of iNOS and COX-2 proteins in LPS-treated RAW 264.7 cells, suggesting that it down-regulated pro-infl ammatory mediators and cytokines. However, although the anti-infl ammatory effects of D-limonene were identifi ed, the mechanisms of action underlying these effects should be evaluated in further studies. It is generally accepted that many intracellular signal pathways participate in the LPS-induced activation of macrophages and resultant production of pro-inflammatory cytokines/ mediators, and that nuclear factor NF -κB and mitogenactivated protein kinase MAPK pathways play key roles. NF-κB is one of the most ubiquitous transcription factors and coordinates the expression of pro-inflammatory enzymes and cytokines, making it a popular target for the development of potent inhibitors as novel anti-infl ammatory drugs [21] [22] [23] [24] . Given the role of NF-κB in modulating the expression of infl ammatory mediators, it is possible that the inhibitory effects of D-limonene involve the inhibition of the NF-κB signalling pathway. However, we cannot exclude the involvement of other transcription factors. IL-1β (B) , and IL-6 (C) concentrations were determined by ELISA. Values are the mean ± SEM of triplicate experiments. *P < 0.05; **P < 0.01
In conclusion, the present study demonstrates the potent cellular anti-inflammatory activity of D-limonene in LPS-activated RAW 264.7 cells. The results indicate that production of NO, PGE 2 , IL-1β, IL-6, and TNF-α is reduced by D-limonene at the protein level in activated macrophages. Furthermore, assessment of cell viability upon treatment of HaCaT human keratinocytes with D-limonene at effective concentrations revealed no apparent cytotoxicity of the terpene, confi rming its suitability for use in cosmetic applications. Thus, D-limonene is a promising candidate anti-infl ammatory agent with potential for use in skin care cosmetics or in the treatment of skin diseases such as acne and atopic dermatitis. The MTT assay was performed after incubation of HaCaT cells treated with various concentrations of D-limonene for 24 h at 37ºC in a 5% CO 2 atmosphere. Absorbance was measured at 570 nm using a spectrophotometer (Power Wave; Bio-Tek, Winooski, VT).
